Recent News

• 02.24.2025 - Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
• 02.24.2025 - Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
• 02.12.2025 - Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
• 02.12.2025 - Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
• 02.05.2025 - Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
• 02.05.2025 - Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
• 02.05.2025 - Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
• 02.05.2025 - Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
• 01.27.2025 - Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
• 01.27.2025 - Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Recent Filings

• 02.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities